The stock of Nevro Corp (NVRO) has gone up by 0.44% for the week, with a 14.47% rise in the past month and a 31.54% rise in the past quarter. The volatility ratio for the week is 0.37%, and the volatility levels for the past 30 days are 3.00% for NVRO. The simple moving average for the last 20 days is 3.73% for NVRO stock, with a simple moving average of -8.68% for the last 200 days.
Is It Worth Investing in Nevro Corp (NYSE: NVRO) Right Now?
The 36-month beta value for NVRO is also noteworthy at 0.94. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 13 rating it as “hold,” and 2 rating it as “sell.”
The public float for NVRO is 35.72M, and at present, short sellers hold a 8.19% of that float. The average trading volume of NVRO on February 26, 2025 was 894.88K shares.
NVRO) stock’s latest price update
Nevro Corp (NYSE: NVRO)’s stock price has increased by 0.09 compared to its previous closing price of 5.73. However, the company has seen a 0.44% increase in its stock price over the last five trading sessions. prnewswire.com reported 2025-02-24 that MILWAUKEE, Feb. 24, 2025 /PRNewswire/ — The Ademi Firm is investigating Nevro (NYSE: NVRO) for possible breaches of fiduciary duty and other violations of law in its transaction with Globus Medical. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.
Analysts’ Opinion of NVRO
Many brokerage firms have already submitted their reports for NVRO stocks, with Jefferies repeating the rating for NVRO by listing it as a “Hold.” The predicted price for NVRO in the upcoming period, according to Jefferies is $5.85 based on the research report published on February 10, 2025 of the current year 2025.
Piper Sandler, on the other hand, stated in their research note that they expect to see NVRO reach a price target of $5.85, previously predicting the price at $6. The rating they have provided for NVRO stocks is “Overweight” according to the report published on February 07th, 2025.
Wells Fargo gave a rating of “Equal Weight” to NVRO, setting the target price at $5 in the report published on December 03rd of the previous year.
NVRO Trading at 22.76% from the 50-Day Moving Average
After a stumble in the market that brought NVRO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -64.42% of loss for the given period.
Volatility was left at 3.00%, however, over the last 30 days, the volatility rate increased by 0.37%, as shares surge +14.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +32.95% upper at present.
During the last 5 trading sessions, NVRO rose by +0.35%, which changed the moving average for the period of 200-days by -43.60% in comparison to the 20-day moving average, which settled at $5.53. In addition, Nevro Corp saw 54.17% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NVRO
Current profitability levels for the company are sitting at:
- -0.2 for the present operating margin
- 0.66 for the gross margin
The net margin for Nevro Corp stands at -0.17. The total capital return value is set at -0.17. Equity return is now at value -24.78, with -11.98 for asset returns.
Based on Nevro Corp (NVRO), the company’s capital structure generated 0.47 points at debt to capital in total, while cash flow to debt ratio is standing at -0.22. The debt to equity ratio resting at 0.9. The interest coverage ratio of the stock is -3.55.
Currently, EBITDA for the company is -78.31 million with net debt to EBITDA at -4.63. When we switch over and look at the enterprise to sales, we see a ratio of 0.93. The receivables turnover for the company is 5.94for trailing twelve months and the total asset turnover is 0.7. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.02.
Conclusion
In summary, Nevro Corp (NVRO) has had a better performance as of late. Analysts have bearish opinions on the stock, with some viewing it as a “sell” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
